President Donald Trump has been celebrating the dose of experimental monoclonal antibodies he was given last Friday, saying he thinks it helped him vanquish his coronavirus infection in record time.
“It was incredible the impact it had,” he said in a video he tweeted Thursday.
What he didn’t say is that the treatment was developed using technology his administration has worked for four years to ban.
It has to do with abortion politics, and the science of using human tissue to test and to make medicines. Regeneron’s therapy indirectly relied on tissue taken from an abortion.
Trump’s base, of course, is strongly against abortion rights and his administration acted quickly to reverse many Obama era policies — including policies that moved forward scientific research involving human fetal tissue.
Especially involved are human embryonic stem cells, made using days-old embryos, usually taken from fertility clinics. They’re
The government of Ghana has hailed the extraordinary role that the Science Granting Councils Initiative (SGCI) has played over the last five years in helping transform Science, Technology and Innovation (STI) in the country.
Special Advisor to the Minister of Environment, Science, Technology and Innovation, Oliver Boachie in an interview said Ghana’s participation in SGCI has seen the nation benefit from capacity building initiatives, as well as other support aimed at putting STI at the center of national development.
“We have received training on research management using grant management systems. That is a whole process of issuing calls for proposals, receiving proposals, vetting, allocation of resources, management of the resources, tracking of the output and so on.”
The SGCI is a multi–funder Initiative aimed at strengthening the capacities of 15 Science Granting Councils in Sub-Saharan Africa in order to support research and evidence-based policies that will contribute to economic and